Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
202M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
103K
-
Shares change
-
0
-
Total reported value, excl. options
-
$146K
-
Price
-
$1.41
Significant Holders of ATAI Life Sciences N.V. - Common Shares (ATAI) as of Q4 2023
1 filings reported holding ATAI - ATAI Life Sciences N.V. - Common Shares as of Q4 2023.
ATAI Life Sciences N.V. - Common Shares (ATAI) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103K shares
of 202M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (3.15M shares), BlackRock Inc. (1.36M shares), MARSHALL WACE, LLP (776K shares), MILLENNIUM MANAGEMENT LLC (761K shares), Brown University (719K shares), Mirae Asset Global Investments Co., Ltd. (624K shares), BANK OF AMERICA CORP /DE/ (559K shares), CITADEL ADVISORS LLC (426K shares), TWO SIGMA INVESTMENTS, LP (416K shares), and VANGUARD GROUP INC (409K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.